Literature DB >> 7924246

Cellular immune status of coronavirus-infected neonatal calves.

S Kapil1, S M Goyal, A M Trent.   

Abstract

A preliminary study was conducted to determine the cellular immune status of neonatal, colostrum-deprived calves following inoculation with either attenuated or virulent bovine coronavirus (BCV). Uninfected calves served as controls. To determine the intestinal and systemic cellular immune status, we performed MHC-restricted cytotoxic lymphocyte (CTL) assay on mesenteric lymphocytes, enumerated T cell subsets in peripheral blood lymphocytes, and examined histopathological alterations in mesenteric lymph nodes and gut-associated lymphoid tissue. Target cells for the CTL assay were autologous testicular cells and effector cells were mesenteric lymphocytes from calves infected with BCV. No appreciable specific lysis was observed in any group of calves indicating the absence of demonstrable CTL responses. The TC/TS population was severely depressed in the calf inoculated with the virulent virus but not in those inoculated with either the attenuated virus or placebo. The mesenteric lymph nodes and Peyer's patches of calves inoculated with the virulent virus showed severe depletion of lymphocytes. These calves developed intestinal antibody responses in the acute phase of infection (1 week after infection) but were immunosuppressed in the later stage of infection.

Entities:  

Mesh:

Year:  1994        PMID: 7924246      PMCID: PMC7134123          DOI: 10.1016/0147-9571(94)90038-8

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  13 in total

1.  Experimental infection with a virulent pneumoenteric isolate of bovine coronavirus.

Authors:  S Kapil; K A Pomeroy; S M Goyal; A M Trent
Journal:  J Vet Diagn Invest       Date:  1991-01       Impact factor: 1.279

2.  Characterization of a subset of bovine T lymphocytes that express BoT4 by monoclonal antibodies and function: similarity to lymphocytes defined by human T4 and murine L3T4.

Authors:  C L Baldwin; A J Teale; J G Naessens; B M Goddeeris; N D MacHugh; W I Morrison
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

3.  Pathology of neonatal calf diarrhea induced by a coronavirus-like agent.

Authors:  C A Mebus; E L Stair; M B Rhodes; M J Twiehaus
Journal:  Vet Pathol       Date:  1973       Impact factor: 2.221

4.  In vitro induction of cytotoxic lymphocytes from infectious bovine rhinotracheitis virus hyperimmune cattle.

Authors:  M Campos; C R Rossi
Journal:  Am J Vet Res       Date:  1986-11       Impact factor: 1.156

5.  Excretion and persistence of bovine coronavirus in neonatal calves.

Authors:  S Kapil; A M Trent; S M Goyal
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Demonstration of cytotoxic lymphocytes to virus-infected target cells in pigs inoculated with transmissible gastroenteritis virus.

Authors:  M Shimizu; Y Shimizu
Journal:  Am J Vet Res       Date:  1979-02       Impact factor: 1.156

7.  Suppressive effects of B-lactam-antibiotics on in vitro generation of cytotoxic T-cells.

Authors:  A W Huegin; A Cerny; R M Zinkernagel; K A Neftel
Journal:  Int J Immunopharmacol       Date:  1986

Review 8.  Rotaviral and coronaviral diarrhea.

Authors:  A Torres-Medina; D H Schlafer; C A Mebus
Journal:  Vet Clin North Am Food Anim Pract       Date:  1985-11       Impact factor: 3.357

9.  Development of nasal, fecal and serum isotype-specific antibodies in calves challenged with bovine coronavirus or rotavirus.

Authors:  L J Saif
Journal:  Vet Immunol Immunopathol       Date:  1987-12       Impact factor: 2.046

10.  Antibody responses in spiral colon, ileum, and jejunum of bovine coronavirus-infected neonatal calves.

Authors:  S Kapil; A M Trent; S M Goyal
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1994-05       Impact factor: 2.268

View more
  1 in total

Review 1.  Autoimmunity as the comet tail of COVID-19 pandemic.

Authors:  Rossella Talotta; Erle Robertson
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.